{"brief_title": "Buprenorphine/Naloxone Treatment for Opioid Dependence-Experiment II-1 - 4", "brief_summary": "The purpose of this study is to assess the abuse liability and examine the reinforcing effects of intravenous buprenorphine and buprenorphine/naloxone combinations in buprenorphine-naloxone maintained volunteers", "detailed_description": "Ongoing study - results not available at this time", "condition": ["Heroin Dependence", "Opioid-Related Disorders"], "intervention_type": ["Drug"], "intervention_name": ["Opioid-Related Disorders"], "criteria": "Inclusion Criteria: Individuals must be at least 18 yrs of age, currently opioid dependent and meet FDA criteria for narcotic maintenance treatment. Co-morbid substance abuse or dependence disorders may also be present. Individuals must be healthy despite drug dependency and have a history of IV opioid use. Exclusion Criteria: Individuals with evidence of anti active Diagnostic and Statistical Manual of Mental Disorders (DSM-IV) Axis I psychiatric disorder (e.g. psychosis, manic-depressive illness, organic psychiatric disorders), significant medical illness (e.g. liver or cardiovascular disease) or pregnant female subjects are excluded from study participation.", "gender": "All", "minimum_age": "18 Years", "maximum_age": "65 Years", "healthy_volunteers": "No", "keyword": "drug dependence", "mesh_term": ["Opioid-Related Disorders", "Heroin Dependence", "Analgesics, Opioid", "Buprenorphine", "Buprenorphine, Naloxone Drug Combination", "Naloxone"], "id": "NCT00000329"}